Bi Asset Management Fondsmaeglerselskab A Cooper Companies, Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$306.88 - $380.0 $182,286 - $225,720	594 Added 34.38%	2,322 $879,000
Q3 2023 Nov 13, 2023	BUY	$315.92 - $397.36 $23,062 - $29,007	73 Added 4.41%	1,728 $550,000
Q2 2023 Aug 03, 2023	BUY	$346.15 - $392.09 $392,880 - $445,022	1,135 Added 218.27%	1,655 $635,000
Q1 2023 May 12, 2023	SELL	$323.56 - $373.36 $5.14 Million - $5.93 Million	-15,888 Reduced 96.83%	520 $194,000
Q4 2022 Feb 13, 2023	BUY	$248.67 - $334.17 $4.08 Million - $5.48 Million	16,408 New	16,408 $5.43 Million
Q4 2020 Feb 12, 2021	SELL	$319.05 - $363.32 $28,395 - $32,335	-89 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$280.08 - $347.78 $24,927 - $30,952	89 New	89 $30,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.